← SynDRA
PEXACERFONT
SynDRA canonical compound SYN0018874 — structure-anchored drug synonym record
| Clinical phase | Phase 2/Phase 3 |
|---|
| Primary target(s) | CRHR1 | PLXNA2 |
|---|
| Mechanism of action | crf receptor antagonist |
|---|
| Indication | generalized anxiety disorder (gad) |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
Mechanisms of action (all sources)
- CRHR1 ANTAGONIST
- Corticotropin releasing factor receptor 1 antagonist
- crf receptor antagonist
Cross-references
Synonyms
- Bms562086
- Dpc-a69448
- BMS-562086
- CRF1 ANTAGONIST
- UNII-LF1VBG4ZUK
- LF1VBG4ZUK
- BMS 562086
- Pexacerfont [USAN:INN]
- Pexacerfont (USAN/INN)
- CHEMBL482950
- SCHEMBL5235999
- BDBM29490
- DTXSID60196675
- CS-6630
- DB12572
- HY-12127
- D10022
- Pyrazolo[1,5-a]-1,3,5-triazine, 13-15
- BMS562086;BMS 562086;BMS-562086
- Pyrazolo(1,5-a)-1,3,5-triazin-4-amine, 8-(6-methoxy-2-methyl-3-pyridinyl)-2,7-dimethyl-N-((1R)-1-methylpropyl)-
- BMS562086
- pexacerfontum
- RefChem:928912
- DTXCID00119166
- Pexacerfont [USAN]
- PEXACERFONT [INN]
- orb1706825
- SCHEMBL29482255
- GTPL10379
- CHEBI:177416
- GLXC-15296
- EX-A3079
- ZB1563
- AKOS040742389
- AC-32621
- DA-66596
- FP170137
- MS-25202
- NS00072040
Look up PEXACERFONT in the interactive SynDRA portal →